Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

The impact of comorbidities on survival in oral cancer patients: a population-based, case-control study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality from cardiovascular disease in women with breast cancer - a nationwide registry study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of human papillomavirus in sinonasal cancer-a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  1. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nasopharyngeal malignancies in Denmark diagnosed from 1980 to 2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Systematic review on the current knowledge and use of Single-cell RNA Sequencing in Head and Neck Cancer

    Research output: Contribution to journalReviewResearchpeer-review

  4. Examination of hearing loss among school-aged children in Greenland

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Risk Factors for Recurrence of Follicular Thyroid Cancer: A Systematic Review

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

BACKGROUND: Comorbidities have shown to highly influence the outcome and risk of death of head and neck cancer patients. The purpose of this study was to examine the comorbidities among oral cavity squamous cell carcinoma (OSCC) patients, and to investigate the impact of comorbidities on overall survival (OS) and recurrence free survival (RFS).

METHODS: Patients diagnosed with OSCC in Eastern Denmark in the period 2000-2014 and treated with curative intend were included. Patients data were linked to the Danish National Patients Register to identify comorbidities based on the Charlson Comorbidity Index (CCI) at the time of diagnosis and five years after diagnosis. Each patient was age-and sex-matched in a 1:10 ratio with an age and sex matched reference group.

RESULTS: A total of 1,183 patients and 11,830 controls were included. Overall this study found comorbidities to be more common among OSCC compared to the reference group both at the time of diagnosis and five years after. The 5-year OS among patients with a CCI score of zero, one, two, and three or above was 60%, 44%, 41%, and 40%, respectively. Similarly, the multivariate cox-regression analysis showed that patients with increasing CCI score also had an increasing risk of death compared to patients with no comorbidities.

CONCLUSION: OSCC patients had significantly higher comorbidity burden at diagnosis and risk of developing additional comorbidities after diagnosis compared to the reference population. Survival outcomes decreased significantly with higher CCI.

Original languageEnglish
JournalActa Oncologica
Volume60
Issue number2
Pages (from-to)173-179
Number of pages7
ISSN0284-186X
DOIs
Publication statusPublished - Feb 2021

    Research areas

  • Oral cavity cancer, comorbidity, Charlson Comorbidity Index (CCI), overall survival, recurrence free survival

ID: 61214906